---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-160293"
form_type: "8-K"
ticker: "RPRX"
cik: "0001802768"
company_name: "Royalty Pharma plc"
filed_at: "2025-07-17T23:59:59+00:00"
generated_at: "2026-05-18T05:59:35.082029+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Royalty Pharma appoints Carole Ho and Elizabeth Weatherman to Board of Directors

## Summary
- Carole Ho (CMO of Denali Therapeutics) and Elizabeth Weatherman (Special LP at Warburg Pincus) appointed effective July 17, 2025.
- Independent board representation increases to >90% following external manager acquisition.
- Both directors determined independent under Nasdaq standards; no family relationships with officers or directors.
- They will receive compensation per Independent Director Compensation Policy detailed in April 2025 Proxy Statement.

## SEC filing metadata
- accession: 0001193125-25-160293
- form_type: 8-K
- ticker: RPRX
- cik: 0001802768
- company_name: Royalty Pharma plc
- filed_at: 2025-07-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1802768/000119312525160293/0001193125-25-160293-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1802768/000119312525160293/d948144d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-160293
- JSON: https://secwatch.observer/filing/0001193125-25-160293.json
- Plain text: https://secwatch.observer/filing/0001193125-25-160293.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.